Trial Watch: Immunotherapeutic strategies on the horizon for hepatocellular carcinoma
10.1080/2162402X.2023.2214478
Saved in:
Main Authors: | Benjamin Koh, Darren Jun Hao Tan, Wen Hui Lim, Jeffrey S L Wong, Cheng Han Ng, Kai En Chan, Meng Wang, Wei Peng Yong, Yock Young Dan, Louis Z Wang, Nigel Tan, Mark Muthiah, Alfred Kow, Nicholas L. Syn, Daniel Q. Huang, Thomas Yau |
---|---|
Other Authors: | MEDICINE |
Format: | Others |
Published: |
Taylor & Francis
2024
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/246739 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Immunotherapeutic potential of extracellular vesicles
by: Zhang, B, et al.
Published: (2020) -
ELUCIDATING THE ROLE OF ADAR1 IN REGULATING IMMUNOTHERAPEUTIC RESPONSE IN MULTIPLE MYELOMA
by: KOH MUN YEE
Published: (2023) -
The relevance of soluble CD137 in the regulation of immune responses and for immunotherapeutic intervention
by: Luu, Khang, et al.
Published: (2023) -
Ectopic CD137 expression by rhabdomyosarcoma provides selection advantages but allows immunotherapeutic targeting
by: Kang Yi Lee, et al.
Published: (2022) -
Computational study on the origin of the cancer immunotherapeutic potential of B and T cell epitope peptides
by: Hao Li, et al.
Published: (2018)